Literature DB >> 12813602

Clostridium difficile-associated diarrhea: predictors of severity in patients presenting to the emergency department.

Christopher N Andrews1, Janet Raboud, Barry O Kassen, Robert Enns.   

Abstract

OBJECTIVE: Experiences with Clostridium difficile-associated diarrhea (CDAD) were reviewed to determine predictors of severity in patients presenting from the community.
METHODS: All patients admitted to two hospitals over 4.5 years with a primary diagnosis of CDAD were reviewed. Patients requiring a hospital stay of greater than 14 days, colectomy, intensive care unit admission or who died were classified as 'severe CDAD' and compared with the remainder of the patients (termed 'mild CDAD').
RESULTS: One hundred fifty-three patients (mean age 63.4+/-20.5 years, range 21 to 93, 64.7% female) were reviewed. Forty-four per cent of the patients had community-acquired CDAD, and the remainder had hospital-acquired disease. There were 44/153 (28.8%) patients with severe CDAD, of which 10/153 (6.5%) died. The severe group had more patients over 70 years old (75% versus 43% in the mild group, OR 3.09, CI 1.81-8.63, P<0.001) and had more comorbid disease (median two major organ systems affected [range zero to five] versus one [range zero to four] in the mild group, OR 1.52, CI 1.27-2.65, P<0.05). Patients with recurrent CDAD were more likely to have severe CDAD (12/44 versus 10/109 in the mild group, OR 4.10, CI 1.47-9.40, P<0.01).
CONCLUSION: Age over 70 years, comorbid illness and CDAD recurrence are significant risk factors for severe disease and a poor outcome in patients admitted to hospital for CDAD.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12813602     DOI: 10.1155/2003/723471

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN: 0835-7900            Impact factor:   3.522


  9 in total

1.  Hospital-acquired Clostridium difficile infection: determinants for severe disease.

Authors:  J M Wenisch; D Schmid; H-W Kuo; E Simons; F Allerberger; V Michl; P Tesik; G Tucek; C Wenisch
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-12-31       Impact factor: 3.267

Review 2.  Clostridium difficile causing acute renal failure: case presentation and review.

Authors:  Jasmin Arrich; Gottfried-H Sodeck; Gurkan Sengolge; Christoforos Konnaris; Marcus Mullner; Anton-N Laggner; Hans Domanovits
Journal:  World J Gastroenterol       Date:  2005-02-28       Impact factor: 5.742

3.  The efficacy of fidaxomicin in the treatment of Clostridium difficile infection in a real-world clinical setting: a Spanish multi-centre retrospective cohort.

Authors:  C Fehér; E Múñez Rubio; P Merino Amador; A Delgado-Iribarren Garcia-Campero; M Salavert; E Merino; E Maseda Garrido; V Díaz-Brito; M J Álvarez; J Mensa
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-10-08       Impact factor: 3.267

4.  Univariate and multivariate analysis of risk factors for severe Clostridium difficile-associated diarrhoea: importance of co-morbidity and serum C-reactive protein.

Authors:  Christian Hardt; Thomas Berns; Wolfgang Treder; Franz-Ludwig Dumoulin
Journal:  World J Gastroenterol       Date:  2008-07-21       Impact factor: 5.742

5.  The impact of pseudomembrane formation on the outcome of Clostridium difficile-associated disease.

Authors:  T Berdichevski; N Keller; G Rahav; S Bar-Meir; R Eliakim; S Ben-Horin
Journal:  Infection       Date:  2013-05-26       Impact factor: 3.553

6.  Predictors of Clostridium difficile infection severity in patients hospitalised in medical intensive care.

Authors:  Nagham Khanafer; Abdoulaye Touré; Cécile Chambrier; Martin Cour; Marie-Elisabeth Reverdy; Laurent Argaud; Philippe Vanhems
Journal:  World J Gastroenterol       Date:  2013-11-28       Impact factor: 5.742

7.  Current status of surgical treatment for fulminant clostridium difficile colitis.

Authors:  Andrew J Klobuka; Alexey Markelov
Journal:  World J Gastrointest Surg       Date:  2013-06-27

8.  Hospital-acquired Clostridium difficile-associated disease in the intensive care unit setting: epidemiology, clinical course and outcome.

Authors:  Alexandre R Marra; Michael B Edmond; Richard P Wenzel; Gonzalo M L Bearman
Journal:  BMC Infect Dis       Date:  2007-05-21       Impact factor: 3.090

Review 9.  Risk factors for recurrence, complications and mortality in Clostridium difficile infection: a systematic review.

Authors:  Claire Nour Abou Chakra; Jacques Pepin; Stephanie Sirard; Louis Valiquette
Journal:  PLoS One       Date:  2014-06-04       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.